Quantcast

Latest Peripheral vascular disease Stories

2011-08-30 12:25:37

More likely to have complications from orthopedic surgery Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes understanding the risk of complications from orthopedic surgery exceedingly important. However, there is a lack of data investigating the incidence of thrombotic and bleeding complications in orthopedic surgery....

2011-08-29 20:08:57

The harmful effects of tobacco smoke on atherosclerosis, one of the driving forces of cardiovascular disease, are greater in women than in men. This result emerges from the large European epidemiological study (Carotid Intima Media thickness and IMT-PROgression as predictors of Vascular Events: the IMPROVE study), funded by EU (Vth Framework Program — Contract n. QLG1-CT-2002-00896). In the IMPROVE study, authors examined 1694 men and 1893 women from Finland, Sweden, Netherlands, France...

2011-08-03 09:00:00

MINNEAPOLIS, Aug. 3, 2011 /PRNewswire/ -- BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have enrolled their first patient in the Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions (PFAST-CTOs) study. The company received approval from the FDA in July, 2011 to move forward with the US based IDE for the peripheral devices and is now actively enrolling patients. The 10 center, 100 patient U.S. PFAST-CTOs study is...

2011-08-01 19:42:58

Nanostructure promotes growth of new blood vessels, mimics natural protein Tissue deprived of oxygen (ischemia) is a serious health condition that can lead to damaged heart tissue following a heart attack and, in the case of peripheral arterial disease in limbs, amputation, particularly in diabetic patients. Northwestern University researchers have developed a novel nanostructure that promotes the growth of new blood vessels and shows promise as a therapy for conditions where increased blood...

2011-07-28 07:25:00

LAKEWOOD, Colo., July 28, 2011 /PRNewswire-USNewswire/ -- The Vascular Disease Foundation (VDF) is pleased to announce that Thomas R. Frieden, MD, MPH, Director, Centers for Disease Control and Prevention will be the keynote speaker at its annual meeting, "Current Issues in Vascular Disease" September 14-15 in McLean, VA. (Logo: http://photos.prnewswire.com/prnh/20110303/DC58830LOGO) A group of nationally recognized experts from VDF will be engaging in discussions on the hottest topics...

2011-07-25 07:36:00

MINNEAPOLIS, July 25, 2011 /PRNewswire/ -- Lutonix today announced the first patient enrolled in the LEVANT 2 clinical trial, a global, multicenter, randomized trial evaluating the safety and efficacy of the Moxy(TM) Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD). The first case was performed at St. John's Hospital in Springfield, IL by Dr. Jeff Goldstein. LEVANT 2 is the first drug-coated balloon IDE trial to be...

2011-07-20 12:27:51

Current issue of Progress in Cardiovascular Diseases explores recent evidence-based vascular medicine As the population ages and obesity and diabetes increase, more people suffer from noncardiac vascular diseases. In the July/August issue of Progress in Cardiovascular Diseases, published by Elsevier, a series of articles from recognized experts on key topics in vascular disease and endovascular medicine provide an insightful compendium of the evidence available to help improve the care of...

2011-06-28 09:56:00

MINNEAPOLIS, June 28, 2011 /PRNewswire/ -- Lutonix today announced receiving approval from the US Food and Drug Administration to begin enrollment in its LEVANT 2 IDE clinical trial for the treatment of peripheral arterial disease (PAD), along with receipt of CE Mark for its drug-coated balloon and ISO certification. Lutonix is the first company to receive approval from the FDA to initiate a drug-coated balloon trial. The company also announced two new additions to its leadership...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related